Frontiers in Immunology (Nov 2022)

IFITM protein regulation and functions: Far beyond the fight against viruses

  • Nela Friedlová,
  • Nela Friedlová,
  • Filip Zavadil Kokáš,
  • Ted R. Hupp,
  • Ted R. Hupp,
  • Bořivoj Vojtěšek,
  • Marta Nekulová

DOI
https://doi.org/10.3389/fimmu.2022.1042368
Journal volume & issue
Vol. 13

Abstract

Read online

Interferons (IFNs) are important cytokines that regulate immune responses through the activation of hundreds of genes, including interferon-induced transmembrane proteins (IFITMs). This evolutionarily conserved protein family includes five functionally active homologs in humans. Despite the high sequence homology, IFITMs vary in expression, subcellular localization and function. The initially described adhesive and antiproliferative or pro-oncogenic functions of IFITM proteins were diluted by the discovery of their antiviral properties. The large set of viruses that is inhibited by these proteins is constantly expanding, as are the possible mechanisms of action. In addition to their beneficial antiviral effects, IFITM proteins are often upregulated in a broad spectrum of cancers. IFITM proteins have been linked to most hallmarks of cancer, including tumor cell proliferation, therapeutic resistance, angiogenesis, invasion, and metastasis. Recent studies have described the involvement of IFITM proteins in antitumor immunity. This review summarizes various levels of IFITM protein regulation and the physiological and pathological functions of these proteins, with an emphasis on tumorigenesis and antitumor immunity.

Keywords